How many institutions held IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

108 institutional investors reported IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Q: What does CUSIP 45256X103 represent in this 13F holders report?

CUSIP 45256X103 is the security identifier for IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45256X103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 1,124,549,707
Total 13F shares: 38,816,393
Share change: -6,739,812
Total reported value: $107,856,591
Put/Call ratio: 88%
Price per share: $2.78
Number of holders: 108
Value change: -$8,601,646
Number of buys: 64
Number of sells: 63

Quarterly Holders Quick Answers

What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 45256X103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	0.74%	8,285,958	$15,080,444	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.62%	6,965,519	$12,677,245	—	31 Mar 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.52%	5,795,927	$10,548,587	—	31 Mar 2023	13F
Cerity Partners LLC	13F	Company	0%	1,000	$5,070,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.24%	2,649,813	$4,822,660	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.22%	2,421,900	$4,407,858	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	1,945,864	$3,541,472	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.14%	1,613,297	$2,936,000	—	31 Mar 2023	13F
SHEETS SMITH WEALTH MANAGEMENT	13F	Company	0.14%	1,590,398	$2,894,524	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.1%	1,095,795	$1,994,347	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.08%	889,699	$1,619,253	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.07%	811,693	$1,477,281	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	715,635	$1,302,456	—	31 Mar 2023	13F
ALLEN HOLDING INC /NY	13F	Company	0.06%	687,571	$1,251,379	—	31 Mar 2023	13F
John C. Thomas	3/4/5	Former Director	— class O/S missing	216,363	$1,086,143	—	31 Dec 2021	3/4/5
MORGAN STANLEY	13F	Company	0.05%	573,766	$1,044,254	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	520,831	$948,000	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.04%	481,915	$877,085	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.04%	440,333	$801,405	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	435,173	$792,015	—	31 Mar 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.04%	399,046	$726,264	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	353,561	$643,481	—	31 Mar 2023	13F
HARBOURVEST PARTNERS LLC	13F	Company	0.03%	335,709	$610,990	—	31 Mar 2023	13F
Clearwater Capital Advisors, LLC	13F	Company	0.03%	317,151	$577,215	—	31 Mar 2023	13F
NEW YORK LIFE INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	262,454	$477,666	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.02%	259,200	$471,744	—	31 Mar 2023	13F
Winning Points Advisors, LLC	13F	Company	0.02%	251,186	$461,000	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	251,558	$457,836	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	244,721	$445,392	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	240,585	$438,000	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.02%	234,441	$426,683	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	224,756	$409,056	—	31 Mar 2023	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	196,436	$358,000	—	31 Mar 2023	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.02%	196,200	$336,000	—	31 Mar 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.02%	182,930	$332,932	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	174,526	$317,637	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.01%	166,758	$304,000	—	31 Mar 2023	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.01%	163,948	$298,385	—	31 Mar 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	0.01%	155,497	$283,004	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	153,089	$278,622	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	152,355	$277,286	—	31 Mar 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	135,933	$247,398	—	31 Mar 2023	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.01%	132,100	$240,404	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	114,378	$208,168	—	31 Mar 2023	13F
FISHMAN JAY A LTD/MI	13F	Company	0.01%	112,000	$203,840	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	111,774	$203,000	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	109,766	$199,000	—	31 Mar 2023	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.01%	107,775	$196,151	—	31 Mar 2023	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	101,469	$195,713	—	31 Mar 2023	13F
Vident Investment Advisory, LLC	13F	Company	0.01%	107,144	$195,002	—	31 Mar 2023	13F

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2023

As of 30 Jun 2023, ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,816,393 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, CREDIT SUISSE AG/, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NATIONAL BANK OF CANADA /FI/, and ALLEN HOLDING INC /NY. This page lists 108 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

141

Q2 2023 holders

108

Holder diff

-33

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.